Table of Contents
ESPS2 : Demographics (modified ITT)
ESPS2: Carotid Endarterectomy (modified ITT)
ESPS2: Primary Endpoint - Stroke
ESPS2 : Secondary Efficacy Endpoint - Non-fatal first stroke
ESPS2: Secondary Efficacy Endpoint - Fatal First Stroke
ESPS2: Stroke with respect to qualifying event
ESPS2: Primary Efficacy Endpoint - Death
PPT Slide
ESPS2:Secondary Efficacy Endpoint - Stroke and Death
ESPS2: Subcategory Contributions-Stroke and Death
ESPS2: Secondary Endpoint - First stroke Handicap Based on a modified Rankin scale
ESPS2: First-Stroke Handicap Categories
ESPS2: First-Stroke Handicap Categories-Modified Rankin Scale of First Stroke
ESPS2:First Non-fatal Stroke Handicap Categories
ESPS2: Secondary Endpoint-Transient Ischemic Attack
ESPS2: Transient Ischemic Attack- Pairwise analysis
ESPS2: Secondary Endpoint TIA by Qualifying Event
ESPS2: First Ischemic Event
ESPS2: First Ischemic Event-Pairwise Analysis
ESPS2: Other Vascular Event by Type of Vascular Event
ESPS2: Adverse Events
ESPS2: Treatment Cessation
ESPS2: Treatment Cessation due to medication side effects
ESPS2: Serious Adverse Events
ESPS2: SAE Hemorrhage and Bleeds
ESPS2:SAE Deaths due to Ulcers and/or bleeds during treatment
U88-0473 and ESPS1 Trials
|